H. Pylori Treatment Drug Pylera Approved
The FDA has given the green light to Axcan Pharma, Inc. to market the drug Pylera for the treatment of H. pylori (Helicobacter pylori). H. pylori is a bacterium that causes gastric and duodenal ulcers.
Each capsule contains biskalcitrate potassium, metronidazole and tetracycline hydrochloride. The patent expires in December 2018.
Filed under Axcan